title: IgA/VCA as a follow-up marker in the monitoring of nasopharyngeal carcinoma.
abstract: Titers of IgA/VCA from 92 nasopharyngeal carcinoma (NPC) patients were monitored for 3 to 11 years from the time of diagnosis. The fluctuations in the IgA/VCA titers during follow-up did not correlate with the clinical status of the patients, suggesting that IgA/VCA is of marginal significance in the monitoring of NPC patients during follow-up. In addition, the frequency of recurrence of NPC was independent of presence or absence of elevated IgA/VCA at diagnosis.
authors.affiliation: Institute of Advanced Studies, University of Malaya, Kuala Lumpur, Malaysia.
authors.forename: C K
authors.initials: CK
authors.lastname: Sam
authors.forename: A J
authors.initials: AJ
authors.lastname: Abu-Samah
authors.forename: U
authors.initials: U
authors.lastname: Prasad
mesh_terms: D000957:Antigens, Viral, Tumor / Q000097:blood*; D014408:Biomarkers, Tumor / Q000097:blood*; D002277:Carcinoma / Q000276:immunology*; D004854:Herpesvirus 4, Human / Q000276:immunology*; D006801:Humans; D007070:Immunoglobulin A / Q000097:blood*; D009303:Nasopharyngeal Neoplasms / Q000276:immunology*; D011237:Predictive Value of Tests; D012008:Recurrence
chemical_list: D000957:Antigens, Viral, Tumor; D014408:Biomarkers, Tumor; D007070:Immunoglobulin A